STEP-1: Semaglutide 2,4 mg, the standard since 2021 The STEP-1 trial (Wilding et al., NEJM 2021, PMID 33567185) randomized 1,961 overweight or obese adults (BMI 30 or BMI 27 with comorbidities) without diabetes to semaglutide 2,4 mg/week or placebo, with lifestyle interventions administered concurrently in both arms
When Retatrutide binds to these receptors, it triggers a cascade of signals that change how your intestines process food, absorb water, and move contents along
Diet & Snacking Guide Many people using Wegovy (semaglutide) for weight management wonder whether they can continue enjoying familiar snacks like popcorn
A non-ST elevation myocardial infarction is a partial blockage
GLP-1 mechanism: central action (satiety) + gastric emptying delay + insulin effect
Caffeinated beverages: While moderate coffee or tea may be okay, excessive caffeine intake can contribute to anxiety and interfere with sleep, worsening other side effects